2010PubMedRequires access

[Study on biological activity of recombinant adeno-associated virus vector co-expressing human vascular endothelial growth factor 165 and human bone morphogenetic protein 7 genes in vitro].

Zhibin Shi, Lihong Fan, Hui Qiang, Yilun Tang, Kunzheng Wang, Xiaoqian Dang

Open publisher page 1 citations

Abstract

OBJECTIVE: To study the biological activity of recombinant adeno-associated virus vector (rAAV) co-expressing human vascular endothelial growth factor 165 (hVEGF165) and human bone morphogenetic protein 7 (hBMP-7) genes in vitro so as to provide a new method for the therapeutics of osteonecrosis. METHODS: The 3rd passage rabbit bone marrow mesenchymal stem cells (BMSCs) were transfected with rAAV-hVEGF165-internal ribosome entry site (IRES)-hBMP-7 (experimental group) and green fluorescent protein (GFP) labeled rAAV-IRES-GFP (control group). The expressions of hVEGF165 and hBMP-7 were detected by ELISA assay at the 1st, 2nd, 3rd, 7th, 14th days and Western blot assay at the 14th day after transfection. The expression consistencies of hVEGF165 and hBMP-7 were observed by immunofluorescence assay at the 14th day after transfection. The biological activity of hVEGF165 was assessed by angiopoiesis experiment of the 3rd passage human umbilical vein endothelial cells (HUVEC). The biological activity of hBMP-7 was assessed by mineralization of BMSCs detected by ALP staining and alizarin red staining. RESULTS: With infecting time, the hVEGF165 and hBMP-7 expressions increased gradually in two groups, showing significant difference between two groups (P < 0.05). The expressions of hVEGF165 and hBMP-7 were positive in experimental group and negative in control group, respectively. Immunofluorescence assay showed positive expressions of hVEGF165 and hBMP-7 in the experimental group and negative expression in the control group, the expression of hVEGF165 and hBMP-7 had good consistencies. hVEGF165 secreted from BMSCs enhanced HUVEC migration, proliferation and tube formation in experimental group. There was significant difference in the number of blood vessel between two groups (P < 0.05). The ALP staining showed more strongly stained granules in experimental group than in control group. There was significant difference in the number of the mineralized nodules between two groups (P < 0.05). CONCLUSION: The rAAV-hVEGF165-IRES-hBMP-7 has good biological activity in vitro.

About this research paper

What this paper is about

OBJECTIVE: To study the biological activity of recombinant adeno-associated virus vector (rAAV) co-expressing human vascular endothelial growth factor 165 (hVEGF165) and human bone morphogenetic protein 7 (hBMP-7) genes in vitro so as to provide a new method for the therapeutics of osteonecrosis. METHODS: The 3rd passage rabbit bone marrow mesenchymal stem cells (BMSCs) were transfected with rAAV-hVEGF165-internal ribosome entry site (IRES)-hBMP-7 (experimental group) and green fluorescent protein (GFP) labeled rAAV-IRES-GFP (control group). The expressions of hVEGF165 and hBMP-7 were detected by ELISA assay at the 1st, 2nd, 3rd, 7th, 14th days and Western blot assay at the 14th day after transfection. The expression consistencies of hVEGF165 and hBMP-7 were observed by immunofluorescence assay at the 14th day after transfection. The biological activity of hVEGF165 was assessed by angiopoiesis experiment of the 3rd passage human umbilical vein endothelial cells (HUVEC). The biological activity of hBMP-7 was assessed by mineralization of BMSCs detected by ALP staining and alizarin red staining. RESULTS: With infecting time, the hVEGF165 and hBMP-7 expressions increased gradually in two groups, showing significant difference between two groups (P < 0.05). The expressions of hVEGF165 and hBMP-7 were positive in experimental group and negative in control group, respectively. Immunofluorescence assay showed positive expressions of hVEGF165 and hBMP-7 in the experimental group and negative expression in the control group, the expression of hVEGF165 and hBMP-7 had good consistencies. hVEGF165 secreted from BMSCs enhanced HUVEC migration, proliferation and tube formation in experimental group. There was significant difference in the number of blood vessel between two groups (P < 0.05). The ALP staining showed more strongly stained granules in experimental group than in control group. There was significant difference in the number of the mineralized nodules between two groups (P < 0.05). CONCLUSION: The rAAV-hVEGF165-IRES-hBMP-7 has good biological activity in vitro.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To study the biological activity of recombinant adeno-associated virus vector (rAAV) co-expressing human vascular endothelial growth factor 165 (hVEGF165) and human bone morphogenetic protein 7 (hBMP-7) genes in vitro so as to provide a new method for the therapeutics of osteonecrosis. METHODS: The 3rd passage rabbit bone marrow mesenchymal stem cells (BMSCs) were transfected with rAAV-hVEGF165-internal ribosome entry site (IRES)-hBMP-7 (experimental group) and green fluorescent protein (GFP) labeled rAAV-IRES-GFP (control group). The expressions of hVEGF165 and hBMP-7 were detected by ELISA assay at the 1st, 2nd, 3rd, 7th, 14th days and Western blot assay at the 14th day after transfection. The expression consistencies of hVEGF165 and hBMP-7 were observed by immunofluorescence assay at the 14th day after transfection. The biological activity of hVEGF165 was assessed by angiopoiesis experiment of the 3rd passage human umbilical vein endothelial cells (HUVEC). The biological activity of hBMP-7 was assessed by mineralization of BMSCs detected by ALP staining and alizarin red staining. RESULTS: With infecting time, the hVEGF165 and hBMP-7 expressions increased gradually in two groups, showing significant difference between two groups (P < 0.05). The expressions of hVEGF165 and hBMP-7 were positive in experimental group and negative in control group, respectively. Immunofluorescence assay showed positive expressions of hVEGF165 and hBMP-7 in the experimental group and negative expression in the control group, the expression of hVEGF165 and hBMP-7 had good consistencies. hVEGF165 secreted from BMSCs enhanced HUVEC migration, proliferation and tube formation in experimental group. There was significant difference in the number of blood vessel between two groups (P < 0.05). The ALP staining showed more strongly stained granules in experimental group than in control group. There was significant difference in the number of the mineralized nodules between two groups (P < 0.05). CONCLUSION: The rAAV-hVEGF165-IRES-hBMP-7 has good biological activity in vitro.

Key concepts: Recombinant DNA, Molecular biology, Transfection, Biology, Bone morphogenetic protein 2, Green fluorescent protein, Bone morphogenetic protein, Immunofluorescence

Related papers

Back to paper searchBrowse research topicsOriginal source
[Study on biological activity of recombinant adeno-associated virus vector co-expressing human vascular endothelial growth factor 165 and human bone morphogenetic protein 7 genes in vitro]. — Research Paper | ScholarLens